Peter Lockey

1.1k total citations
34 papers, 876 citations indexed

About

Peter Lockey is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Peter Lockey has authored 34 papers receiving a total of 876 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Organic Chemistry. Recurrent topics in Peter Lockey's work include Receptor Mechanisms and Signaling (9 papers), Retinoids in leukemia and cellular processes (5 papers) and Estrogen and related hormone effects (5 papers). Peter Lockey is often cited by papers focused on Receptor Mechanisms and Signaling (9 papers), Retinoids in leukemia and cellular processes (5 papers) and Estrogen and related hormone effects (5 papers). Peter Lockey collaborates with scholars based in United Kingdom, United States and Netherlands. Peter Lockey's co-authors include Hazel J. Dyke, Melanie Wong, David E. Clark, Alan G. Roach, Dennis Norman, Harvey Wong, Maxine Norman, Benjamin P. Fauber, Alberto Gobbi and Adam R. Johnson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Clinical Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Peter Lockey

34 papers receiving 838 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Lockey United Kingdom	18	385	214	164	135	113	34	876
Gisele Nishiguchi United States	10	304 0.8×	299 1.4×	57 0.3×	148 1.1×	441 3.9×	19	941
J.C. Nwachukwu United States	20	550 1.4×	187 0.9×	168 1.0×	168 1.2×	420 3.7×	33	1.2k
Shubin Sheng United States	10	398 1.0×	179 0.8×	60 0.4×	119 0.9×	601 5.3×	11	992
Jen‐Shin Song Taiwan	22	625 1.6×	346 1.6×	150 0.9×	273 2.0×	18 0.2×	58	1.4k
Michael A. Stashko United States	23	708 1.8×	340 1.6×	491 3.0×	160 1.2×	116 1.0×	51	1.5k
Lautaro D. Álvarez Argentina	12	234 0.6×	108 0.5×	65 0.4×	60 0.4×	193 1.7×	32	512
Eddine Saiah United States	21	468 1.2×	300 1.4×	45 0.3×	68 0.5×	19 0.2×	31	973
Hazel J. Dyke United Kingdom	20	468 1.2×	382 1.8×	82 0.5×	34 0.3×	39 0.3×	30	911
Sergey E. Tkachenko Russia	22	880 2.3×	772 3.6×	79 0.5×	185 1.4×	511 4.5×	71	1.9k
Chun Wel Lin United States	13	183 0.5×	178 0.8×	28 0.2×	70 0.5×	103 0.9×	25	567

Countries citing papers authored by Peter Lockey

Since Specialization

Citations

This map shows the geographic impact of Peter Lockey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Lockey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Lockey more than expected).

Fields of papers citing papers by Peter Lockey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Lockey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Lockey. The network helps show where Peter Lockey may publish in the future.

Co-authorship network of co-authors of Peter Lockey

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Lockey. A scholar is included among the top collaborators of Peter Lockey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Lockey. Peter Lockey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Clark, David E., Bohdan Waszkowycz, Melanie Wong, et al.. (2016). Application of virtual screening to the discovery of novel nicotinamide phosphoribosyltransferase (NAMPT) inhibitors with potential for the treatment of cancer and axonopathies. Bioorganic & Medicinal Chemistry Letters. 26(12). 2920–2926. 16 indexed citations

Fauber, Benjamin P., Alberto Gobbi, Pascal Savy, et al.. (2015). Identification of N-sulfonyl-tetrahydroquinolines as RORc inverse agonists. Bioorganic & Medicinal Chemistry Letters. 25(19). 4109–4113. 10 indexed citations

Fauber, Benjamin P., Olivier René, Yuzhong Deng, et al.. (2015). Discovery of 1-{4-[3-Fluoro-4-((3 S ,6 R )-3-methyl-1,1-dioxo-6-phenyl-[1,2]thiazinan-2-ylmethyl)-phenyl]-piperazin-1-yl}-ethanone (GNE-3500): a Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor C (RORc or RORγ) Inverse Agonist. Journal of Medicinal Chemistry. 58(13). 5308–5322. 46 indexed citations

Fauber, Benjamin P., Olivier René, Brenda Burton, et al.. (2014). Identification of tertiary sulfonamides as RORc inverse agonists. Bioorganic & Medicinal Chemistry Letters. 24(9). 2182–2187. 22 indexed citations

Fauber, Benjamin P., Olivier René, Gladys de Leon Boenig, et al.. (2014). Reduction in lipophilicity improved the solubility, plasma–protein binding, and permeability of tertiary sulfonamide RORc inverse agonists. Bioorganic & Medicinal Chemistry Letters. 24(16). 3891–3897. 39 indexed citations

Clark, David E., Christopher Higgs, Marcel J. de Groot, et al.. (2014). From virtual to clinical: The discovery of PGN-1531, a novel antagonist of the prostanoid EP4 receptor. Bioorganic & Medicinal Chemistry Letters. 24(9). 2212–2221. 8 indexed citations

Zalachoras, Ioannis, René Houtman, Erika Atucha, et al.. (2013). Differential targeting of brain stress circuits with a selective glucocorticoid receptor modulator. Proceedings of the National Academy of Sciences. 110(19). 7910–7915. 92 indexed citations

Fitzgerald, Mary, et al.. (2013). The in vitro profile of ADC3680, a potent and selective CRTh2 antagonist for the treatment of inadequately controlled asthma. European Respiratory Journal. 42(Suppl 57). P735–P735. 4 indexed citations

Fauber, Benjamin P., Gladys de Leon Boenig, Brenda Burton, et al.. (2013). Structure-based design of substituted hexafluoroisopropanol-arylsulfonamides as modulators of RORc. Bioorganic & Medicinal Chemistry Letters. 23(24). 6604–6609. 49 indexed citations

10.

Hunt, Hazel, Nicholas C. Ray, George W. Hynd, et al.. (2012). Discovery of a novel non-steroidal GR antagonist with in vivo efficacy in the olanzapine-induced weight gain model in the rat. Bioorganic & Medicinal Chemistry Letters. 22(24). 7376–7380. 22 indexed citations

11.

Dyke, Hazel J., Christopher Higgs, David E. Clark, et al.. (2010). Identification and hit-to-lead exploration of a novel series of histamine H4 receptor inverse agonists. Bioorganic & Medicinal Chemistry Letters. 20(8). 2516–2519. 24 indexed citations

12.

Clark, Robin D., Nicholas C. Ray, Karen Williams, et al.. (2008). 1H-Pyrazolo[3,4-g]hexahydro-isoquinolines as selective glucocorticoid receptor antagonists with high functional activity. Bioorganic & Medicinal Chemistry Letters. 18(4). 1312–1317. 40 indexed citations

13.

Ray, Nicholas C., Robin D. Clark, David E. Clark, et al.. (2007). Discovery and optimization of novel, non-steroidal glucocorticoid receptor modulators. Bioorganic & Medicinal Chemistry Letters. 17(17). 4901–4905. 24 indexed citations

14.

Clark, Robin D., Nicholas C. Ray, Paul Blaney, et al.. (2007). 2-Benzenesulfonyl-8a-benzyl-hexahydro-2H-isoquinolin-6-ones as selective glucocorticoid receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 17(20). 5704–5708. 7 indexed citations

15.

Dyke, Hazel J., Peter Lockey, Dennis Norman, et al.. (2006). Quinazoline and benzimidazole MCH-1R antagonists. Bioorganic & Medicinal Chemistry Letters. 17(5). 1403–1407. 17 indexed citations

16.

Price, Steve, Walter Bordogna, Richard J. Bull, et al.. (2006). Identification and optimisation of a series of substituted 5-pyridin-2-yl-thiophene-2-hydroxamic acids as potent histone deacetylase (HDAC) inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(2). 363–369. 25 indexed citations

17.

Crofts, Frances, Shashank Rohatagi, P. Brunel, et al.. (2004). Critical period for a teratogenic VLA‐4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non‐teratogenic VLA‐4 antagonists. Birth Defects Research Part B Developmental and Reproductive Toxicology. 71(2). 69–79. 13 indexed citations

18.

Clark, David E., Hazel J. Dyke, Peter Lockey, et al.. (2004). Structure–activity relationships of a novel series of melanin-concentrating hormone (MCH) receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 14(15). 4099–4102. 36 indexed citations

19.

Brown, Thomas J., Paul Alan Cox, Frank Halley, et al.. (1998). Identification of a non peptidic RANTES antagonist. Bioorganic & Medicinal Chemistry Letters. 8(7). 771–774. 9 indexed citations

20.

Lockey, Peter, et al.. (1984). Synthesis and cytotoxic activity of estrogen α-methylene-δ-lactones. Steroids. 43(3). 283–292. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact